Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Farooq V, et al. Among authors: meliga e. Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7. Lancet. 2013. PMID: 23439103
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.
Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I. Biondi-Zoccai GG, et al. Among authors: meliga e. Am Heart J. 2008 Feb;155(2):274-83. doi: 10.1016/j.ahj.2007.10.009. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18215597 Review.
Adipose-derived cells.
Meliga E, Strem BM, Duckers HJ, Serruys PW. Meliga E, et al. Cell Transplant. 2007;16(9):963-70. doi: 10.3727/096368907783338190. Cell Transplant. 2007. PMID: 18293895 Free article. Review.
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW; DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E, et al. J Am Coll Cardiol. 2008 Jun 10;51(23):2212-9. doi: 10.1016/j.jacc.2008.03.020. J Am Coll Cardiol. 2008. PMID: 18534266 Free article.
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.
Chieffo A, Park SJ, Meliga E, Sheiban I, Lee MS, Latib A, Kim YH, Valgimigli M, Sillano D, Magni V, Biondi-Zoccai G, Montorfano M, Airoldi F, Rogacka R, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Sangiorgi GM, Tobis J, Serruys PW, Colombo A. Chieffo A, et al. Among authors: meliga e. Eur Heart J. 2008 Sep;29(17):2108-15. doi: 10.1093/eurheartj/ehn270. Epub 2008 Jun 18. Eur Heart J. 2008. PMID: 18565967
94 results